Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) Short Interest Up 195.9% in October

Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) saw a large growth in short interest during the month of October. As of October 31st, there was short interest totalling 14,500 shares, a growth of 195.9% from the October 15th total of 4,900 shares. Based on an average daily trading volume, of 28,800 shares, the short-interest ratio is presently 0.5 days.

Invesco Nasdaq Biotechnology ETF Trading Down 2.4 %

NASDAQ:IBBQ traded down $0.59 on Tuesday, reaching $23.77. 4,204 shares of the stock traded hands, compared to its average volume of 19,497. Invesco Nasdaq Biotechnology ETF has a 12 month low of $18.34 and a 12 month high of $24.84. The company has a market capitalization of $38.75 million, a price-to-earnings ratio of 17.39 and a beta of 0.61. The company’s fifty day simple moving average is $23.86 and its 200 day simple moving average is $23.30.

Invesco Nasdaq Biotechnology ETF Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, September 27th. Stockholders of record on Monday, September 23rd were paid a $0.089 dividend. This is an increase from Invesco Nasdaq Biotechnology ETF’s previous quarterly dividend of $0.05. This represents a $0.36 dividend on an annualized basis and a dividend yield of 1.50%. The ex-dividend date was Monday, September 23rd.

Hedge Funds Weigh In On Invesco Nasdaq Biotechnology ETF

Institutional investors and hedge funds have recently made changes to their positions in the business. ORG Partners LLC bought a new position in shares of Invesco Nasdaq Biotechnology ETF during the third quarter worth $25,000. Lake Street Advisors Group LLC purchased a new position in Invesco Nasdaq Biotechnology ETF in the first quarter worth about $286,000. Finally, Mirae Asset Global Investments Co. Ltd. increased its position in shares of Invesco Nasdaq Biotechnology ETF by 22.7% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 259,733 shares of the company’s stock valued at $6,156,000 after purchasing an additional 48,137 shares during the last quarter.

About Invesco Nasdaq Biotechnology ETF

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.